CAR T細胞治療による難治性B細胞リンパ腫の5年経過

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma2017 · 6,068 citations
2. 2Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas2017 · 1,881 citations
3. 3KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma2020 · 1,866 citations
4. 4Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial2018 · 2,301 citations
5. 5Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma2018 · 4,140 citations